Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Operating activities    
Net income/(loss) $ 867 $ (6,085)
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:    
Depreciation and amortization 5,291 5,762
Amortization of deferred debt issuance costs 223 258
Stock compensation expense 1,178 1,133
Deferred income taxes 491 (654)
Release of reserve for uncertain tax positions, net 19 0
(Gain)/Loss on long-term cross currency swap 61 1,805
Remeasurement gain on intercompany balances (1,493) (3,153)
Loss on sale of business, net of cash surrendered 311 0
Changes in operating assets and liabilities:    
Accounts receivable 1,209 21,248
Inventories 39 (7,914)
Contract assets (3,456) 1,794
Other current and non-current assets (691) (903)
Accounts payable 2,501 (4,341)
Accrued liabilities and non-current liabilities (3,259) (1,801)
Income taxes payable and receivable (814) (3,797)
Net cash provided by/(used in) operating activities 2,477 3,352
Investing activities    
Purchases of property, plant and equipment (873) (2,059)
Sale of rental equipment 21 6
Net cash provided by/(used in) in investing activities (852) (2,053)
Financing activities    
Proceeds from revolving credit facility 7,959 37,189
Payments on long-term debt and revolving credit facility (8,759) (34,294)
Proceeds from exercise of stock options 97 437
Repurchase of employee stock units on vesting (548) (557)
Payments on finance leases (40) (74)
Net cash provided by/(used in) financing activities (1,291) 2,701
Effect of exchange rate changes on cash, cash equivalents and restricted cash 604 1,009
Cash, cash equivalents and restricted cash at beginning of period 42,450 46,007
Cash, cash equivalents and restricted cash at end of period 43,388 51,016
Change in cash, cash equivalents and restricted cash $ 938 $ 5,009